Anivance AI
PrivateLast Round
Seed
Nov 30, 2024
Total Funding Raised
$2.23M
Company Overview
Anivance AI operates in Healthcare & Life Sciences and is based in Taiwan. Its latest recorded funding round was a Seed round in November 2024.
Anivance AI is a biotechnology company that develops AI-enabled organ-on-chip and microphysiological systems to generate human-relevant preclinical data for drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Medical AI, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Subscription SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anivance AI Comparables
Compare Anivance AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xellar Biosystems | 85% | |
| Pythia Biotech | 84% | |
| Emulate | 82% |
For institutional investors. Book with your work email.
Anivance AI Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Anivance AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Accelerator |
| BE Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 24, 2025
Grew 67% QoQ, from 12 to 20 employees.
- Nov 14, 2025
Grew 33% QoQ, from 12 to 16 employees.
For institutional investors. Book with your work email.
Anivance AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Anivance AI's valuation, stock price, and market status.
Is Anivance AI a public or private company?
Anivance AI is a private company.
What is the current stock price of Anivance AI?
Anivance AI is a private company, so its shares have no public market price. Caplight tracks Anivance AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Anivance AI worth (valuation)?
Valuation information for Anivance AI is not publicly available.
Can I buy Anivance AI stock?
Anivance AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Anivance AI's last funding round?
Anivance AI's most recent funding round was Seed on November 30, 2024.
Who are the main investors in Anivance AI?
Key investors in Anivance AI include Plug and Play Tech Center, BE Accelerator.
Will Anivance AI IPO soon?
No public IPO plans have been announced for Anivance AI.
How can I track Anivance AI secondary market activity?
Caplight tracks bids, offers, and trades in Anivance AI's shares on secondary markets.